EPHA2 and non-small cell lung carcinoma: Phosphoproteomic profiling of NSCLC cells in which Ephrin B3 expression was inhibited revealed lack of both EphA2 Ser897 and Akt Ser129 phosphorylations, indicating a signaling interaction between Ephrin B3 and EphA2 [19].